Effect of Peri-Urethral Stimulation on Intra-Urethral Pressure
Stress Urinary Incontinence
About this trial
This is an interventional other trial for Stress Urinary Incontinence
Eligibility Criteria
Inclusion Criteria: Female aged 18 years old or older Capable of understanding the clinical study procedures and giving informed consent Willing and able to undergo the study procedure Diagnosis of SUI or stress predominant mixed incontinence, for at least 6 months Provided authorization to use and disclose information for research purposes Exclusion Criteria: Predominant urge incontinence per patient report or medical record Previously diagnosed with Interstitial Cystitis Active symptomatic uncontrolled bladder instability as determined by the investigator Regularly or intermittently used a urethral catheter Active bladder cancer (currently undergoing or scheduled to undergo treatment for bladder cancer). Previous radiation treatment in the pelvic floor Three or more culture-proven bacterial UTIs in the last 12 months History or symptoms of cystocele, enterocele or rectocele of grade 3 or 4. Per the medical record or as determined by the investigator Current infection (urethritis, cystitis or vaginitis) as determined by investigator. Active herpes genitalis Unevaluated hematuria BMI ≥ 35 Currently taking, or has taken within 4 weeks prior to the screening/baseline visit, pharmacological treatment for SUI (including but not limited to, alpha adrenergics, and tricyclic antidepressants) Severe or uncontrolled diabetes, (defined as being a diabetic with a hemoglobin A1c of ≥10%) per patient medical record. History of drug/alcohol abuse, mental dysfunction, or other factors limiting her ability to cooperate fully Pregnancy test with positive result during screening or women who are breastfeeding Women who are pregnant and/or have given birth in the previous 12 months Have implanted neurostimulators, pacemakers, or defibrillators Known systemic neurological dysfunctions Severe coagulation disorders Medically unstable at time of study and unsafe to undergo urodynamic testing (UDT) as determined by the investigator Presence of an artificial urinary sphincter Any medical condition (e.g. Multiple Sclerosis, spinal cord injury, mobility) or uncontrolled chronic disease (e.g. renal diseases that requires dialysis) that would interfere with the patient's ability to comply with the protocol and/or may affect the outcome of this study or safety of the subject as determined by the investigator
Sites / Locations
- Beaumont Hospital-Royal Oak
Arms of the Study
Arm 1
Experimental
Urodynamic testing and LLP with and without pudendal nerve stimulation
Commercially available stimulation needles will be inserted into the peri-urethral space targeting the perineal branch of the pudendal nerve. An external neurostimulator settings will be adjusted to deliver acute stimulation. Urodynamic testing will be completed by filling the bladder to a set volume and observing for urinary leakage. The assessment will be completed with stimulation turned on and off. The neurostimulator device settings will be adjusted by the investigator to stay within safe and comfortable levels for each individual study participant.